Fingerprint
Dive into the research topics of 'A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer
Erica L. Mayer, Jean Francois Baurain, Joseph Sparano, Lewis Strauss, Mario Campone, Pierre Fumoleau, Hope Rugo, Ahmad Awada, Oumar Sy, Antonio Llombart-Cussac
Research output: Contribution to journal › Article › peer-review
88
Scopus
citations